AVIGEN(avgn) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AVIGEN(avgn)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (142)	9/4/1999 11:26:00 AM
From: Mike McFarland	Read Replies (1) of 228

Correction: The PNAS website is pnas.org --not dot com, whoops. Here are a few things to check out--I assume the first AAV success will be CF or Hemophilia, see "High Noon For Gene Therapy" at Signalsmag.com and this post Message 10287265 --nobody ever followed up to Walkingshadow's post, somebody who knows what Avigen is up to might do that. This might be a good read, I guess I'm going to have to subscribe... Mark A. Kay and Katherine High Gene therapy for the hemophilias PNAS 1999 96: 9973-9975. Looks like it might be one of those articles which summarizes the various efforts

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next